56 completed, 10 terminated, 4 withdrawn. 37 Phase 2, 29 Phase 1, 7 Not applicable, 1 Early Phase 1, 1 Phase 3.
Follow Recurrent Ovarian Epithelial Cancer: new trials by email Literature Review of Recurrent Ovarian Epithelial Cancer trials Research Report on Recurrent Ovarian Epithelial Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer metformin hydrochloride, placebo, Chemotherapy - Brenner Tumor, Malignant Ascites | Phase 2 | Completed | University of Chicago | 111 | 2015-02-25 | 2026-03-27 |
| p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer modified vaccinia virus ankara vaccine expressing p53, gemcitabine hydrochloride, laboratory biomarker analysis - Recurrent Ovarian Epithelial Cancer, Recurrent Fallopian Tube Carcinoma | Phase 1 | Completed | City of Hope Medical Center | 12 | 2015-02-06 | 2026-10-14 |
| Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer palliative care, educational intervention, quality-of-life assessment - Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor | Not applicable | Withdrawn | City of Hope Medical Center | 2014-12-01 | 2014-12-23 | |
| Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine, IDO1 inhibitor INCB024360, laboratory biomarker analysis - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 / Phase 2 | Withdrawn | Roswell Park Cancer Institute | 2013-12-01 | 2013-12-18 | |
| Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection vorinostat, diagnostic laboratory biomarker analysis, pharmacological study - HIV Infection, Recurrent Anal Cancer | Phase 1 | Terminated | AIDS Malignancy Consortium | 17 | 2013-11-01 | 2020-07-29 |
| Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer mifepristone, carboplatin, gemcitabine hydrochloride - Male Breast Cancer, Recurrent Breast Cancer | Phase 1 | Completed | University of Chicago | 31 | 2013-11-01 | 2018-09-11 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers educational intervention, telephone-based intervention, quality-of-life assessment - Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter | Not applicable | Completed | City of Hope Medical Center | 200 | 2013-10-29 | 2026-10-01 |
| Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer paclitaxel, ganetespib, laboratory biomarker analysis - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 / Phase 2 | Terminated | Fox Chase Cancer Center | 12 | 2013-10-09 | 2024-03-26 |
| Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer auranofin, laboratory biomarker analysis - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Early Phase 1 | Completed | Mayo Clinic | 10 | 2012-11-02 | 2019-08-02 |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine, sirolimus, laboratory biomarker analysis - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | Roswell Park Cancer Institute | 7 | 2012-08-20 | 2020-03-27 |
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2012-05-01 | 2012-07-09 | |
| Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer stereotactic body radiation therapy, carboplatin, gemcitabine hydrochloride - Leydig Cell Tumor, Ovarian Sarcoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 12 | 2012-05-01 | 2015-08-04 |
| Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer stereotactic body radiation therapy, positron emission tomography, computed tomography - Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor | Phase 1 | Terminated | Stanford University | 1 | 2012-04-01 | 2017-04-28 |
| A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer everolimus, carboplatin, pegylated liposomal doxorubicin hydrochloride - Fallopian Tube Cancer, Peritoneal Cavity Cancer | Phase 1 | Completed | Fox Chase Cancer Center | 21 | 2010-12-14 | 2019-07-11 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors veliparib, capecitabine, oxaliplatin - Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach | Phase 1 | Terminated | National Cancer Institute (NCI) | 16 | 2010-10-01 | 2014-04-02 |
| Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer questionnaire administration, quality-of-life assessment, psychosocial assessment and care - Anxiety Disorder, Depression | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 39 | 2010-10-01 | 2015-10-09 |
| SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin SJG-136, laboratory biomarker analysis - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 19 | 2010-07-01 | 2015-05-25 |
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Terminated | City of Hope Medical Center | 1 | 2010-07-01 | 2019-06-18 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) HIPEC Orientation, Consultation with Survivorship Navigator, Questionnaires - Advanced Malignant Mesothelioma, Carcinoma of the Appendix | Not applicable | Completed | Wake Forest University Health Sciences | 10 | 2010-05-01 | 2018-07-03 |
Showing 20 of 70. Sign in to see all of them.
Carcinoma, Ovarian Epithelial (70) · Fallopian Tube Neoplasms (31) · Breast Neoplasms (18) · Carcinoma, Non-Small-Cell Lung (10) · Uterine Cervical Neoplasms (9) · Colonic Neoplasms (8) · Endometrial Neoplasms (8) · Stomach Neoplasms (8) · Breast Neoplasms, Male (7) · Pancreatic Neoplasms (7) · Congenital Abnormalities (6) · Leukemia, Myeloid, Acute (6) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (6) · Rectal Neoplasms (6) · Squamous Cell Carcinoma of Head and Neck (6)
Adnexal Diseases (70) · Carcinoma (70) · Endocrine Gland Neoplasms (70) · Endocrine System Diseases (70) · Female Urogenital Diseases (70) · Female Urogenital Diseases and Pregnancy Complications (70) · Genital Diseases (70) · Genital Diseases, Female (70) · Genital Neoplasms, Female (70) · Gonadal Disorders (70) · Neoplasms by Histologic Type (70) · Neoplasms by Site (70) · Neoplasms, Glandular and Epithelial (70) · Ovarian Diseases (70) · Ovarian Neoplasms (70)
Carboplatin (7) · Taxes (6) · Gemcitabine (5) · Paclitaxel (5) · Cisplatin (4) · Sirolimus (4) · Early Intervention, Educational (3) · Erlotinib Hydrochloride (3) · Granulocyte-Macrophage Colony-Stimulating Factor (3) · Interleukin-12 (3) · Interleukin-12 Subunit p35 (3) · Methods (3) · Radiosurgery (3) · liposomal doxorubicin (3) · sargramostim (3)
National Cancer Institute (NCI) (43) · City of Hope Medical Center (5) · Roswell Park Cancer Institute (4) · Fox Chase Cancer Center (3) · University of Washington (3) · Case Comprehensive Cancer Center (2) · Fred Hutchinson Cancer Center (2) · University of Chicago (2) · AIDS Malignancy Consortium (1) · Mayo Clinic (1) · Ohio State University Comprehensive Cancer Center (1) · Stanford University (1) · University of Southern California (1) · Wake Forest University Health Sciences (1)
United States (65) · Canada (5)
Agustin Garcia (3) · Amit Oza (3) · Kunle Odunsi (3) · Gina Martina-Smaldone, MD (2) · Russell Schilder (2) · William Carson (2) · Aminah Jatoi, M.D. (1) · Amy Tiersten (1) · Angela Jain (1) · Antonius Miller (1) · Barbara Andersen, PhD (1) · Barbara Goff (1) · Betty Ferrell (1) · Brigitte Miller (1) · Carol Aghajanian (1)
PMID 18974373, PMID 19238149, PMID 20357034, PMID 21752435, PMID 21935916, PMID 21992853, PMID 22541066, PMID 22664059, PMID 24172094, PMID 25895616, PMID 28817727, PMID 35254001, PMID 35429391, PMID 37185961, PMID 39362046, PMID 40132910
U10CA027469 (11), N01CM62203 (4), N01CM62201 (3), N01CM62209 (3), P30CA015083 (3), N01CM17101 (2), N01CM62204 (2), N01CM62205 (2), P30CA006927 (2), P30CA014599 (2), U01CA076576 (2), N01CM00100 (1), N01CM17003 (1), N01CM62206 (1), P01CA087971 (1)